What will move the SP?19 May 2022 10:41
Collaboration with Janssen in December, followed by a second collaboration in March and an IND from the FDA relating to MTX110 only made the SP head in the wrong direction!
The problem is this stock is being shorted and has been since 2019 by Armistice Capital. Its a dangerous game as news could drop at any time to burn shorts, though no doubt Armistice have measures in place to foresee such data before us minions.
I am encouraged by the fundamentals of the business, though the current situation is dire for private investors, with the threat of a reverse split on the NASDAQ to keep above $1.00
Management need to identify the 'low hanging fruit' of their many patents and/or announce a longstanding partnership to remove the risk of placing in the coming months.
This is a £100m+ company in the making. Just at this moment in time it feels a 100 million miles from this.